Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 CNY
−71.95 M CNY
2.23 B CNY
576.98 M
About JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT
Sector
CEO
Qun Shan Qian
Headquarters
Suzhou
Website
Founded
1994
ISIN
CNE000000YP4
FIGI
BBG000BLNYR1
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. engages in the research and development, production and sales of pharmaceuticals. Its products include organic pigments, cosmetics, dyes and their intermediates. The company was founded on April 14, 1994 and is headquartered in Suzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600200 is 8.88 CNY — it has increased by 0.11% in the past 24 hours. Watch JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT stocks are traded under the ticker 600200.
600200 stock has fallen by −3.06% compared to the previous week, the month change is a −4.52% fall, over the last year JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT has showed a −4.52% decrease.
We've gathered analysts' opinions on JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT future price: according to them, 600200 price has a max estimate of 13.00 CNY and a min estimate of 12.70 CNY. Watch 600200 chart and read a more detailed JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT stock forecast: see what analysts think of JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT and suggest that you do with its stocks.
600200 reached its all-time high on Jun 3, 2015 with the price of 42.47 CNY, and its all-time low was 1.76 CNY and was reached on Nov 4, 2008. View more price dynamics on 600200 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600200 stock is 2.28% volatile and has beta coefficient of 1.46. Track JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT stock price on the chart and check out the list of the most volatile stocks — is JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT there?
Today JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT has the market capitalization of 6.31 B, it has decreased by −3.17% over the last week.
Yes, you can track JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT financials in yearly and quarterly reports right on TradingView.
JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
600200 net income for the last quarter is 20.63 M CNY, while the quarter before that showed 19.40 M CNY of net income which accounts for 6.34% change. Track more JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT financial stats to get the full picture.
As of Jan 30, 2025, the company has 1.05 K employees. See our rating of the largest employees — is JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT on this list?
Like other stocks, 600200 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT stock shows the sell signal. See more of JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.